HopeStage
Back to all studies
WithdrawnNCT03729791

The Effect of tDCS on Schizophrenia With Negative Symptoms

Device studyAges 18–50South Korea
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 50 years.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: December 1, 2019
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
Seoul National University Hospital
Sponsor type
Hospital / academic medical center
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
South Korea
Age range
From 18 Years to 50 Years
Official registry ID
NCT03729791
Official title
Show the full official title

Clinical Trials for Neuroimaging and Electrophysiology in Schizophrenic Patients With Negative Symptoms Using Transcranial Direct Current Stimulation

Recruitment & locations

Withdrawn

Seoul

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Seoul National University Hospital, a hospital or academic medical center.

Who can participate?

Listed age limits: 18 years to 50 years.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies